Cerebras has been in a sustained downtrend since its IPO on May 14, 2026, with a 1-year price change of -16.41% (though the stock has only traded for about 7 weeks). The current price of $204.86 sits at 19.4% above its 52-week low of $160.81 and 47.0% below its 52-week high of $386.34, indicating it is closer to the low end of its range. This positioning suggests the stock is in a bearish phase, potentially offering a value opportunity if fundamentals support a recovery, but also risks further downside if negative momentum persists.

Revenue trajectory is robust, with estimated revenue of $7.18 billion for the current fiscal year, though quarterly financials are not available. The company has a net margin of 46.6%, indicating strong profitability on a net income basis, but operating margin is deeply negative at -28.5%, reflecting high operating expenses. Gross margin of 39.0% is moderate for a semiconductor company, but recent news highlights disappointing gross margin guidance, suggesting compression. The company is profitable with EPS of $0.0036, but ROE is -41.1%, indicating poor returns on equity. The debt-to-equity ratio of -0.45 suggests negative equity, a red flag for financial health, while the current ratio of 2.14 provides adequate liquidity. Free cash flow data is not available, but the negative PCF ratio of -6661.8 implies negative cash flow from operations, raising concerns about the company's ability to fund growth internally.